Most of the measurable health benefit of walking arrives by about 7,000 steps a day, according to a 2025 review of 57 studies spanning more than a decade of step-tracking research. Pushing on to the familiar 10,000-step target adds little beyond that point for most outcomes the researchers measured, a finding that undercuts a number treated for sixty years as an unofficial daily prescription.
That 10,000 figure did not come from a laboratory. It came from a Japanese clockmaker’s marketing department in the run-up to the 1964 Tokyo Olympics, when a Tokyo clinic director’s concern about sedentary habits turned into a product name rather than a peer-reviewed recommendation.
The Study Behind the New 7,000-Step Figure
Melody Ding, a professor at the University of Sydney’s School of Public Health, led the analysis with co-author Katherine Owen, pulling together 57 studies from more than ten countries collected between 2014 and 2025. Comparing 7,000 daily steps against a sedentary baseline of 2,000, an American College of Cardiology summary of the meta-analysis reported a 47% lower risk of dying from any cause, a 47% lower risk of dying from cardiovascular disease specifically, and a 25% lower risk of developing cardiovascular disease in the first place, drawn from datasets covering more than 100,000 participants each. Benefits for several outcomes, including cardiovascular disease, essentially plateaued past that point, a pattern consistent with the broader step-count evidence summary stating that most health benefit can be obtained by around 7,000 steps a day.
Not every outcome flattened at the same number. The university’s own announcement of the findings reported a 38% lower dementia risk at 7,000 steps with only marginal further gains at higher counts, while type 2 diabetes risk kept falling further out, dropping 22% at 10,000 steps and 27% at 12,000. Ding, describing the practical takeaway from a review that assessed health outcomes in areas earlier step-count research had not covered, called “aiming for 7000 steps a realistic goal.” Owen, the study’s co-author, put the diminishing-returns finding plainly, noting that beyond 7,000 steps the extra benefit for most of the health outcomes examined turned out to be modest.
A 1965 Marketing Campaign Chose the Wrong Number First
The 10,000-step figure predates any of that research by six decades. In 1965, the Japanese company Yamasa Tokei Keiki released a pedometer called the manpo-kei, literally “10,000-step meter,” timed to ride the fitness enthusiasm generated by the Tokyo Olympics the previous year. Harvard Medical School epidemiologist Lee has traced the number to essentially a branding choice rather than a health finding, telling a magazine feature on the origin of the figure that “it was a made-up number in the sense that 10,000 sounds good, it’s easy to remember,” and noting separately that the Japanese character for 10,000 resembles a walking figure, a visual pun that likely helped the name stick commercially.
Lee’s own research years later found that older women who averaged around 4,400 steps a day had significantly lower mortality than those averaging roughly 2,700, with benefits continuing to accrue up to about 7,500 steps before leveling off, a number close to the figure the 2025 meta-analysis later confirmed across a far larger and more diverse pool of studies. Both findings independently point away from 10,000 as a biologically meaningful threshold and toward a number closer to 7,000, arrived at decades apart using different populations and methods.
Age Changes the Number That Matters
The plateau point is not fixed across every age group. The Centers for Disease Control and Prevention’s own physical activity guidance notes that mortality risk for adults under 60 continued dropping until roughly 8,000 to 10,000 daily steps, while adults 60 and older saw benefits level off earlier, around 6,000 to 8,000 steps, a gap the agency attributes to differences in baseline fitness and how quickly additional activity translates into cardiovascular strain versus benefit at different ages. The same federal guidance estimates that 110,000 deaths a year among Americans 40 and older could be avoided if that group collectively raised its activity levels, a number built on the same underlying dose-response relationship between daily movement and mortality that the newer steps research quantifies in finer detail.
The newer figures do not argue that walking further is harmful, only that the marginal payoff shrinks well before 10,000 steps for most people and most outcomes. A person already walking 12,000 steps a day gains real, measurable protection against diabetes specifically that someone stopping at 7,000 does not get, which is why researchers have stopped short of replacing one flat number with another. The number that matters, six decades after a Japanese pedometer maker picked one out of marketing convenience rather than evidence, now depends on which disease a person is trying to avoid and how old they are when they start counting.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- Early electric-car owners are hitting battery and screen failures no one warned them about
- A magnitude 5.3 quake struck off the Oregon coast this week
- Amazon’s Prime refunds are rising to $200 as millions more customers become eligible
- A handful of car engines are so tough mechanics say they almost never wear out
